These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 199389)

  • 1. Cytotoxicity of circulating leukocytes in cytomegalovirus mononucleosis.
    Lemon SM; Hutt LM; Huang YT
    Clin Immunol Immunopathol; 1977 Nov; 8(3):513-9. PubMed ID: 199389
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of antibodies to EB virus in infectious mononucleosis patients.
    Sobéslavský O; Kouba K; Lasovská J; Pokorný J; Kucharska Z; Vojtĕchovský K; Seeman J; Syrcek L
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(3):370-6. PubMed ID: 4342924
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of the Epstein-Barr virus and cytomegalovirus antibody demonstration in the diagnosis of infectious mononucleosis].
    Schmitz H
    Verh Dtsch Ges Inn Med; 1972; 78():930-3. PubMed ID: 4353157
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mononucleosis syndromes].
    Lifshitz A; Aguilar-Zaragoza CA; Reyes-Arguelles A; Rodríguez-Moguel L
    Gac Med Mex; 1990; 126(5):393-400. PubMed ID: 1983304
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus and cytomegalovirus antibodies in infectious mononucleosis.
    Gergely L; Czeglédy J; Szalka A; Váczi L; Binder L
    Acta Microbiol Acad Sci Hung; 1977; 24(1):13-9. PubMed ID: 201153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and Guillain-Barrè syndrome.
    Reller LB
    Lancet; 1973 Jan; 1(7795):151. PubMed ID: 4118492
    [No Abstract]   [Full Text] [Related]  

  • 7. An immunological approach to the infectious mononucleosis syndrome.
    Diosi P; David C
    Virologie; 1981; 32(2):171-3. PubMed ID: 6264664
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.
    Lai PK; Mackay-Scollay EM; Fimmel PJ; Alpers MP; Keast D
    Nature; 1974 Dec; 252(5484):608-10. PubMed ID: 4372559
    [No Abstract]   [Full Text] [Related]  

  • 9. Etiology and laboratory diagnosis of infectious mononucleosis: II. Cytomegalovirus (CMV) mononucleosis.
    Escobar MR; Allison MJ; Dalton HP
    Va Med Mon (1918); 1970 Mar; 97(3):191-2. PubMed ID: 4367827
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Epstein-Barr viral antibodies and leukocyte-transforming agent in infectious mononucleosis.
    Chang RS; Cooper TY; Simpson EE
    N Engl J Med; 1976 Jun; 294(25):1404-5. PubMed ID: 177877
    [No Abstract]   [Full Text] [Related]  

  • 11. Neutralizing antibodies to Epstein-Barr virus in healthy populations and patients with infectious mononucleosis.
    Hewetson JF; Rocchi G; Henle W; Henle G
    J Infect Dis; 1973 Sep; 128(3):283-9. PubMed ID: 4353929
    [No Abstract]   [Full Text] [Related]  

  • 12. [Infectious mononucleosis. Determination of immunofluorescent antibodies against the Epstein-Barr virus and complement-fixation antibodies against the cytomegalovirus].
    Lasovská J; Kouba K; Sobĕslavský O; Seeman J; Moravcová E; Kucharská Z; Vojtĕchovský K
    Cas Lek Cesk; 1973 Jan; 112(2):38-42. PubMed ID: 4345614
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical, laboratory and serological observations in infectious mononucleosis].
    Ternák G; Szücs G; Nemes Z; Horváth G
    Orv Hetil; 1981 Mar; 122(10):569-75. PubMed ID: 6265847
    [No Abstract]   [Full Text] [Related]  

  • 14. Human T-cell cultures from virus-sensitized donors can mediate virus-specific and HLA-restricted cell lysis.
    Sethi KK; Stroehmann I; Brandis H
    Nature; 1980 Aug; 286(5774):718-20. PubMed ID: 6251371
    [No Abstract]   [Full Text] [Related]  

  • 15. Infectious-mononucleosis-like disease with negative heterophil agglutination test. Clinical features in relation to Epstein-Barr virus and cytomegalovirus antibodies.
    Klemola E; Von Essen R; Henle G; Henle W
    J Infect Dis; 1970 Jun; 121(6):608-14. PubMed ID: 4316146
    [No Abstract]   [Full Text] [Related]  

  • 16. EBV specific killer T cells and serologic responses after onset of infectious mononucleosis.
    Svedmyr E; Jondal M; Henle W; Weiland O; Rombo L; Klein G
    J Clin Lab Immunol; 1978 Nov; 1(3):225-32. PubMed ID: 228038
    [No Abstract]   [Full Text] [Related]  

  • 17. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
    Wilson GL; Young BG
    Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
    [No Abstract]   [Full Text] [Related]  

  • 18. Infectious mononucleosis with atypical manifestations accompanied by transient IgM antibody response for cytomegalovirus.
    Nishikawa J; Funada H; Miyazaki T; Fujinami H; Miyazono T; Murakami J; Kudo T; Sugiyama T
    J Infect Chemother; 2011 Oct; 17(5):686-8. PubMed ID: 21327688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Virological aspects.
    Edwards JM
    J Clin Pathol; 1973 Dec; 26(12):987. PubMed ID: 4361580
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Infectious mononucleosis in children.
    Nakao T; Chiba S; Ikeda S
    Pediatrics; 1975 Jun; 55(6):897. PubMed ID: 166350
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.